Market Overview:
Microelectrode arrays (MEAs) are devices that allow for the electrical recording of signals from a population of cells. MEAs are used in vitro to study the electrophysiology of cells, including cardiac cells, neurons, and other cell types. The global microelectrode array in vitro market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of this market is primarily driven by the increasing demand for classical MEA, multiwell-MEA, and CMOS-MEA products from research institutes and pharmaceutical companies across the globe. The classical MEA segment is expected to hold the largest share of the global microelectrode array in vitro market during the forecast period. This segment is mainly driven by its low cost and high accuracy compared with other types of MEAs available in the market.
Product Definition:
A microelectrode array in vitro is a device that allows for the testing of multiple electrodes in parallel. This type of device is often used to study the electrophysiology of cells or tissues.
Classical MEA:
Classical Middle East and Africa, is a part of the MEA market which has been experiencing steady growth over the past few years. The key drivers for this market are increasing healthcare expenditure in the region coupled with rising awareness about advanced technologies.
The overall healthcare expenditure in GCC countries was estimated to be around USD 110 billion as of 2011.
Multiwell-MEA:
Multiwell-MEA is a well-established microelectrode array in vitro technology that has been used for more than two decades. It allows the preparation of arrays of different types and sizes of wells, which can be used for various purposes such as detection or identification of biomarkers or proteins, measurement of electrical activities at single cells level, etc. Multiwell-MEA plates are available with different numbers and shapes of wells to suit a wide rangeof applications.
Application Insights:
The others application segment accounted for the largest revenue share in 2016 and is anticipated to witness significant growth during the forecast period. This can be attributed to growing usage of MEA in various other applications such as cell biology, drug discovery, stem cells research and bioengineering. The cardiomyocytes application segment is also expected to witness lucrative growth over the forecast period owing to increasing adoption of MEA for mapping out cardiac electrical activity.
Microelectrode arrays are widely used for researching about nervous system function & development since they provide a cost-effective alternative method compared with traditional techniques such as patch clamping or extracellular recording. They have enabled researchers to study neural circuitries that underlie learning & memory through electrophysiology techniques such as voltage-clamp and multi-channel pipette filling assays using cell types natively found within the mammalian central nervous system (CNS).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate for advanced technologies, and increased research & development activities by these companies. Moreover, increasing government funding for R&D on neurological diseases is also expected to drive regional growth over the forecast period. Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to factors such as improving healthcare infrastructure and growing medical tourism in emerging economies like India and China.
The MEA region consists of countries like Saudi Arabia, UAE, Iran & Qatar where there are significant investments being made by various private as well as public entities due to favorable climatic conditions (arid/dryness).
Growth Factors:
- Increasing demand for miniaturized and high-throughput devices in drug discovery and development processes
- Rising prevalence of chronic diseases that require continuous monitoring of biomarkers
- Growing number of clinical trials being conducted to assess the efficacy and safety of novel therapeutics
- Proliferation of nanotechnology-based products for microelectrode array applications
- Advances in electrode fabrication techniques that reduce manufacturing costs
Scope Of The Report
Report Attributes
Report Details
Report Title
Microelectrode Array in Vitro Market Research Report
By Type
Classical MEA, Multiwell-MEA, CMOS-MEA
By Application
Cardiomyocytes, Nerve, Others
By Companies
MaxWell Biosystems, Axion Biosystems, 3Brain, Multi Channel Systems MCS GmbH, Med64
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Microelectrode Array in Vitro Market Report Segments:
The global Microelectrode Array in Vitro market is segmented on the basis of:
Types
Classical MEA, Multiwell-MEA, CMOS-MEA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiomyocytes, Nerve, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MaxWell Biosystems
- Axion Biosystems
- 3Brain
- Multi Channel Systems MCS GmbH
- Med64
Highlights of The Microelectrode Array in Vitro Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Classical MEA
- Multiwell-MEA
- CMOS-MEA
- By Application:
- Cardiomyocytes
- Nerve
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microelectrode Array in Vitro Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microelectrode Array in Vitro is a technology that uses micro-sized electrodes to measure electrical activity in biological cells and tissues.
Some of the major companies in the microelectrode array in vitro market are MaxWell Biosystems, Axion Biosystems, 3Brain, Multi Channel Systems MCS GmbH, Med64.
The microelectrode array in vitro market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microelectrode Array in Vitro Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microelectrode Array in Vitro Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microelectrode Array in Vitro Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microelectrode Array in Vitro Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microelectrode Array in Vitro Market Size & Forecast, 2018-2028
4.5.1 Microelectrode Array in Vitro Market Size and Y-o-Y Growth
4.5.2 Microelectrode Array in Vitro Market Absolute $ Opportunity
Chapter 5 Global Microelectrode Array in Vitro Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Microelectrode Array in Vitro Market Size Forecast by Type
5.2.1 Classical MEA
5.2.2 Multiwell-MEA
5.2.3 CMOS-MEA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Microelectrode Array in Vitro Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Microelectrode Array in Vitro Market Size Forecast by Applications
6.2.1 Cardiomyocytes
6.2.2 Nerve
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microelectrode Array in Vitro Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microelectrode Array in Vitro Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Microelectrode Array in Vitro Analysis and Forecast
9.1 Introduction
9.2 North America Microelectrode Array in Vitro Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Microelectrode Array in Vitro Market Size Forecast by Type
9.6.1 Classical MEA
9.6.2 Multiwell-MEA
9.6.3 CMOS-MEA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Microelectrode Array in Vitro Market Size Forecast by Applications
9.10.1 Cardiomyocytes
9.10.2 Nerve
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Microelectrode Array in Vitro Analysis and Forecast
10.1 Introduction
10.2 Europe Microelectrode Array in Vitro Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Microelectrode Array in Vitro Market Size Forecast by Type
10.6.1 Classical MEA
10.6.2 Multiwell-MEA
10.6.3 CMOS-MEA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Microelectrode Array in Vitro Market Size Forecast by Applications
10.10.1 Cardiomyocytes
10.10.2 Nerve
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Microelectrode Array in Vitro Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Microelectrode Array in Vitro Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Microelectrode Array in Vitro Market Size Forecast by Type
11.6.1 Classical MEA
11.6.2 Multiwell-MEA
11.6.3 CMOS-MEA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Microelectrode Array in Vitro Market Size Forecast by Applications
11.10.1 Cardiomyocytes
11.10.2 Nerve
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Microelectrode Array in Vitro Analysis and Forecast
12.1 Introduction
12.2 Latin America Microelectrode Array in Vitro Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Microelectrode Array in Vitro Market Size Forecast by Type
12.6.1 Classical MEA
12.6.2 Multiwell-MEA
12.6.3 CMOS-MEA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Microelectrode Array in Vitro Market Size Forecast by Applications
12.10.1 Cardiomyocytes
12.10.2 Nerve
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Microelectrode Array in Vitro Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Microelectrode Array in Vitro Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Microelectrode Array in Vitro Market Size Forecast by Type
13.6.1 Classical MEA
13.6.2 Multiwell-MEA
13.6.3 CMOS-MEA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Microelectrode Array in Vitro Market Size Forecast by Applications
13.10.1 Cardiomyocytes
13.10.2 Nerve
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microelectrode Array in Vitro Market: Competitive Dashboard
14.2 Global Microelectrode Array in Vitro Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MaxWell Biosystems
14.3.2 Axion Biosystems
14.3.3 3Brain
14.3.4 Multi Channel Systems MCS GmbH
14.3.5 Med64
